Company Name:Mylan NV
CEO: Heather M. Bresch

Sector: Health Technology

Exchange: NASDAQ

Country: GB

Description: Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.


Key numbers

Market Capitalization:8788099000
Shares Outstanding: 516947000
Float: 513776564
Next Earning Date:2020-08-06
TTm EPS: 0.1178
TTm Dividend Rate:
200 days moving average:17.79
50 days moving average: 16.54
One day percent Change: -1.35



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,